Ms Brooke Kelly Bateman, MA | |
2026 Oh-45, Austinburg, OH 44010 | |
(440) 275-3019 | |
Not Available |
Full Name | Ms Brooke Kelly Bateman |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 2026 Oh-45, Austinburg, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245708858 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Brooke Kelly Bateman, MA 556 Janet Dr, Conneaut, OH 44030-3078 Ph: (440) 265-8803 | Ms Brooke Kelly Bateman, MA 2026 Oh-45, Austinburg, OH 44010 Ph: (440) 275-3019 |
News Archive
A study looking at the personal perceptions and experiences of patients, families and healthcare professionals, has highlighted the need for improvement in symptom management in end of life care.
New research from the University of Alabama at Birmingham suggests that young patients with acute lymphocytic leukemia, or ALL — the most common type of pediatric cancer — and their parents are likely to report to their physician that they took more of their anti-cancer medication than they actually did.
This collaboration is carried out within the GastricGlycoExplorer consortium, a European Commission funded project. The consortium aims at discovering and developing new diagnostic signatures by characterizing the sugars that are attached to the surface of gastric tissue. "Glycomics" provides a systematic approach for studying sugars that are naturally present on cell surfaces and its application may lead to determine early markers of gastric cancer.
Simon Fraser University associate professor James Wakeling is adding to the arsenal of increasingly sophisticated medical imaging tools with a new signal-processing method for viewing muscle activation details that have never been seen before.
New Haven Pharmaceuticals, Inc. today announced new study data that shows the company's FDA-approved drug DURLAZA delivers sustained antiplatelet control for a full 24-hour period in high-risk patients.
› Verified 3 days ago
Mr. Thomas Jeffrey Pierce-ruhland, OTR/L,CLT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2026 State Route 45, Austinburg, OH 44010 Phone: 440-678-8577 |